Inventor · disambiguated record
Lisa Kim Gilliland
Also filed as: GILLILAND LISA K · GILLILAND LISA KIM
13 granted patents·5 pending applications·1,413 citations·filing 1993–2020
95Inventor score
Files withBRISTOL MYERS SQUIBB CO8WALDMANN HERMAN3BRISTOL MEYERS SQUIBB CO1CYTOMX THERAPECUTICS INC1CYTOMX THERAPEUTICS INC1
Top patents by PatentIndex Score
18 records- 0198US6132992AExpression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cellBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Oct 17, 2000·387 cites·54 claims
- 0298US5637481AExpression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cellBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jun 10, 1997·331 cites·22 claims
- 0397US6010902AAntibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activityBRISTOL MEYERS SQUIBB CO·Filed 1994·Granted Jan 4, 2000·262 cites·28 claims
- 0494US6482919B2Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cellBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 19, 2002·68 cites·6 claims
- 0591US7465790B2Therapeutic antibodiesISIS INNOVATION INC·Filed 2001·Granted Dec 16, 2008·67 cites·4 claims
- 0691US5876950AMonoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapyBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Mar 2, 1999·115 cites·50 claims
- 0786US5795572AMonoclonal antibodies and FV specific for CD2 antigenBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Aug 18, 1998·68 cites·24 claims
- 0884US8440190B2Antibody variantsWALDMANN HERMAN·Filed 2005·Granted May 14, 2013·4 cites·13 claims
- 0984US6384198B1Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigenBRISTOL MYERS SQUIBB CO·Filed 1995·Granted May 7, 2002·54 cites·4 claims
- 1083US8623357B2Therapeutic antibodiesWALDMANN HERMANN·Filed 2008·Granted Jan 7, 2014·8 cites·4 claims
- 1178US7915395B2Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cellBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Mar 29, 2011·10 cites·14 claims
- 1277US5807734AMonoclonal antibodies and FV specific for CD2 antigenBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 15, 1998·39 cites·2 claims
- 1369US2021269544A1Therapeutic antibodiesCYTOMX THERAPECUTICS INC·Filed 2020·Application pending·0 cites
- 1460US10800850B2Therapeutic antibodiesCYTOMX THERAPEUTICS INC·Filed 2015·Granted Oct 13, 2020·0 cites·17 claims
- 1560US2014212418A1Therapeutic AntibodiesWALDMANN HERMAN·Filed 2013·Application pending·0 cites
- 1649US2004109855A1Therapeutic antibodies with reduced side effectFiled 2003·Application pending·0 cites
- 1745US2013028893A1Therapeutic antibodies with reduced side effectWALDMANN HERMAN·Filed 2011·Application pending·0 cites
- 1827US2002048578A1Antibody variantsFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lisa Kim Gilliland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →